Author:
Arpey Christopher J.,Annest Nicole M.,Tucker Stephen B.,Petersen Erik T.,Rapini Ronald P.,MacFarlane Deborah F.
Publisher
Springer International Publishing
Reference108 articles.
1. Olsen EA. The pharmacology of methotrexate. J Am Acad Dermatol. 1991;25:306–18.
2. Wong PT, Choi SK. Mechanisms and implications of dual-acting methotrexate in folate-targeted nanotherapeutic delivery. Int J Mol Sci. 2015;16(1):1772–90.
3. Tsai CW, Lai FJ, Sheu HM, et al. WWOX suppresses autophagy for inducing apoptosis in methotrexate-treated human squamous cell carcinoma. Cell Death Dis. 2013;4:e792.
4. Siviero Dillenburn C, Domingues Martins M, Meurer L, et al. Keratoacanthoma of the lip: activation of the mTOR pathway, tumor suppressor proteins, and tumor senescence. Medicine. 2015;94(38):e1552.
5. Glantz MJ, Jaeckle KA, Chamberlain MC, et al. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Clin Cancer Res. 1999;5:3394–402.